Pharma4ever A/S: Financial statements 2023
CVR: 36436573
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma4ever A/S (CVR 36436573) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 15,279,185 and a net result of DKK 3,943,774 compared with DKK 2,655,077 the year before. That is an increase of 17.4% compared with the year before. Equity in the 2023 report amounted to DKK 4,528,313. The solvency ratio was 46.3%. The company had 13 employees in the financial year.
- Gross Profit
- DKK 15,279,185
- Profit/Loss
- DKK 3,943,774
- Equity
- DKK 4,528,313
- Total Assets
- DKK 9,778,894
- Employees
- 13
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 15.3 mio. | 3.9 mio. | 4.5 mio. | 13 |
| 2022 | - | 13 mio. | 2.7 mio. | 3.2 mio. | 12 |
| 2021 | - | 8.9 mio. | 1.7 mio. | 2.3 mio. | 8 |
| 2020 | - | 8.8 mio. | 1.8 mio. | 1.6 mio. | 7 |
| 2019 | - | 7.4 mio. | 1.1 mio. | 1.8 mio. | 7 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharma4ever A/S has published its annual report for 2022. Gross profit came to DKK 13,009,830, and the net result was DKK 2,655,077.
About Pharma4ever A/S
Pharma4ever A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named PHARMA4EVER ApS. The management consists of Bo Hejgaard Pedersen and Per Rønsholt Andresen. The board consists of Jonas Mortensen Højslet (chair), Per Rønsholt Andresen and Susanne Andersen. The company is owned by BHP Holding ApS and Andresen Holding af 29. maj 2015 ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 16,332,858 and a net result of DKK 2,714,802 compared with DKK 2,416,208 the year before. Equity in the 2025 report amounted to DKK 3,214,802.